U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
March 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dutch Bros, Phreesia and Starbucks on Tuesday.
HIGHLIGHTS
Dutch Bros Inc BROS.N: Exane BNP Paribas initiates coverage with outperform rating |
Phreesia Inc PHR.N: JP Morgan cuts to neutral from overweight |
Starbucks SBUX.O: Exane BNP Paribas initiates coverage with underperform rating |
Terns Pharmaceuticals Inc TERN.O: Truist Securities cuts to hold from buy |
Wingstop Inc WING.O: Exane BNP Paribas initiates coverage with outperform rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
Abbott ABT.N: BTIG cuts target price to $131 from $140 |
Amphenol Corp APH.N: Jefferies assumes coverage with buy vs hold rating |
Amphenol Corp APH.N: Jefferies assumes coverage with target price $145 vs $150 |
Anaptysbio Inc ANAB.O: Piper Sandler raises target price to $95 from $67 |
Automatic Data Processing Inc ADP.O: TD Cowen cuts target price to $208 from $255 |
Cava Group Inc CAVA.N: Exane BNP Paribas initiates coverage with neutral rating |
Cava Group Inc CAVA.N: Exane BNP Paribas initiates coverage with target price $91 |
Chipotle Mexican Grill CMG.N: Exane BNP Paribas initiates coverage with neutral rating |
Chipotle Mexican Grill CMG.N: Exane BNP Paribas initiates coverage with PT $37 |
CVS Health Corp CVS.N: Piper Sandler cuts target price to $99 from $101 |
Dutch Bros Inc BROS.N: Exane BNP Paribas initiates coverage with outperform rating |
Dutch Bros Inc BROS.N: Exane BNP Paribas initiates coverage with target price $73 |
Emerson EMR.N: Jefferies assumes coverage with buy vs hold rating; PT $175 vs $160 |
Esab Corp ESAB.N: Jefferies assumes coverage with buy rating; PT $130 vs $150 |
Flowserve Corp FLS.N: Jefferies assumes coverage with buy rating; PT $90 vs $100 |
Hayward Holdings Inc HAYW.N: Jefferies assumes coverage with hold rating |
Hayward Holdings Inc HAYW.N: Jefferies assumes coverage with price target $15 vs $16 |
Jack In the Box Inc JACK.O: Stifel cuts target price to $10 from $18 |
Lincoln Electric Holdings LECO.O: Jefferies assumes coverage with hold vs buy rating |
Lincoln Electric Holdings LECO.O: Jefferies assumes coverage with PT $280 vs $350 |
Maze Therapeutics Inc MAZE.O: JP Morgan raises target price to $58 from $52 |
Merck & Co Inc MRK.N: Jefferies raises target price to $138 from $132 |
Middleby Corp MIDD.O: Jefferies assumes coverage with buy rating; target price $195 |
MSA Safety Inc MSA.N: Jefferies assumes coverage with hold rating; PT $180 vs $200 |
Paycom Software Inc PAYC.N: TD Cowen raises target price to $148 from $137 |
Paylocity Holding Corp PCTY.O: TD Cowen cuts target price to $155 from $178 |
Phreesia Inc PHR.N: D.A. Davidson cuts target price to $14 from $30 |
Phreesia Inc PHR.N: JP Morgan cuts to neutral from overweight |
Phreesia Inc PHR.N: JP Morgan cuts target price to $16 from $24 |
Progress Software Corp PRGS.O: D.A. Davidson cuts target price to $40 from $50 |
Progress Software Corp PRGS.O: Jefferies cuts target price to $34 from $45 |
Rockwell Automation Inc ROK.N: Jefferies assumes coverage with hold vs buy rating |
Rockwell Automation Inc ROK.N: Jefferies assumes coverage with PT $380 vs $490 |
Shake Shack Inc SHAK.N: Exane BNP Paribas initiates coverage with outperform rating |
Shake Shack Inc SHAK.N: Exane BNP Paribas initiates coverage with target price $124 |
Starbucks SBUX.O: Exane BNP Paribas initiates coverage with underperform rating |
Starbucks SBUX.O: Exane BNP Paribas initiates coverage with target price $84 |
Sweetgreen Inc SG.N: Exane BNP Paribas initiates coverage with underperform rating |
Sweetgreen Inc SG.N: Exane BNP Paribas initiates coverage with target price $4.5 |
Terns Pharmaceuticals Inc TERN.O: Truist Securities cuts to hold from buy |
Terns Pharmaceuticals Inc TERN.O: Truist Securities cuts target price to $53 from $56 |
Thermo Fisher Scientific Inc TMO.N: Jefferies reinstates coverage with buy rating |
Thermo Fisher Scientific Inc TMO.N: Jefferies reinstates coverage with PT $600 |
USA Rare Earth Inc USAR.O: Canaccord Genuity cuts target price to $29 from $33 |
Veralto Corp VLTO.N: Jefferies assumes coverage with buy vs hold rating |
Veralto Corp VLTO.N: Jefferies assumes coverage with target price $110 vs $105 |
Vertiv Holdings Co VRT.N: Jefferies assumes coverage with hold vs buy rating |
Vertiv Holdings Co VRT.N: Jefferies assumes coverage with target price $260 vs $280 |
Viridian Therapeutics Inc VRDN.O: Jefferies cuts target price to $29 from $45 |
Wabtec Corp WAB.N: Jefferies assumes coverage with buy rating; PT $290 vs $300 |
Wingstop Inc WING.O: Exane BNP Paribas initiates coverage with outperform rating |
Wingstop Inc WING.O: Exane BNP Paribas initiates coverage with target price $275 |
Xylem Inc XYL.N: Jefferies assumes coverage with hold rating; PT $130 vs $140 |
